A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

Please provide your email address to receive an email when new articles are posted on . Miller-Owen: Close to 8 million U.S. residents with diabetes are on insulin therapy, and the clear majority use ...

One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Brown leatherette covered hinged case ...